IGF1R and breast carcinoma: In recent studies, it has been shown that syndecan-1 regulates VE-cadherin and VEGF-mediated activation of ανβ3 integrin and, via IGF-IR, induce cell proliferation in metastatic breast cancer cells22, 23, 24, 25.